Join our daily newsletter At The Bell to receive exclusive market insights
- Pro Medicus’ (PME) German subsidiary, Visage Imaging, has signed a $10 million contract with Ludwig-Maximilians-Universität (LMU)
- This seven year contract will see Pro Medicus’ Visage 7 technology be deployed across all of LMU’s radiology and imaging departments
- This will see the existing legacy picture archiving and communications system be replaced with a single centralised Visage 7 platform
- Visage 7 delivers quick, multi-dimensional images that are streamed through an intelligent thin-client viewer
- Implementation is scheduled to begin in December 2020
- Pro Medicus is currently up 7.14 per cent on the market with shares trading for $31.08 each
Pro Medicus’ (PME) German subsidiary, Visage Imaging, has signed a $10 million contract with Ludwig-Maximilians-Universität (LMU).
This seven year contract will see Pro Medicus’ Visage 7 technology be deployed across all of LMU’s radiology and imaging departments.
This will see the existing legacy picture archiving and communications system (PACS) be replaced with a single centralised Visage 7 platform.
Implementation is scheduled to begin in December 2020.
“We look forward to taking our partnership with Visage to the next level as we implement their technology across our radiology department,” LMU Chief Information Officer Dr Kurt Kruber commented.
“The Visage platform provides a highly scalable and reliable platform combined with sophisticated clinical features that will support us in both day-to-day patient care and advance research,” he said.
Visage 7 delivers quick, multi-dimensional images that are streamed through an intelligent thin-client viewer (essentially a web-based document viewing and collaboration tool).
“We are very excited about this project. LMU is a thought leader in making a digital strategy a core principle of their operations,” Visage Imaging Managing Director Dr Malte Westerhoff said.
“We are confident that our technology and expertise can make a significant contribution to helping LMU further enhance efficiency and achieve better patient outcomes,” he added.
Pro Medicus is up 7.14 per cent on the market with shares trading for $31.08 each at 2:56 pm AEDT.
